EffPha – 由專家領軍的CRO,為您的藥物開發提供全方位支持
廠商名稱:精睿醫藥科技股份有限公司
發佈日期:2025-06-26
攤位號碼:M919
Efficient Pharma Management Corp. (EffPha) is a full-service CRO providing drug development services, including strategic and technical consulting, biostatistics, data management, regulatory dossier preparation and submission, and clinical study management and monitoring.
EffPha has established a team of experts with over 30 years of drug development experience from global pharmaceutical companies since founded. That EffPha is an expert-based CRO is the brand positioning by providing advice based on practical industry experience from domestic and international new drug development companies.
We knew an experienced and talented drug development team can not only provide decision-makers with the best strategies of drug development, advise and direct clinical operations, but also identify potential risks in drug development, which allows them to further plan risk management or adjust the direction of product development. Therefore, it would help shorten drug development timelines and mitigate risks for biotech and pharmaceutical companies, allocating development resources more efficiently.
EffPha excels at proposing the most suitable drug development strategies, designing clinical trials with high success rates, and providing high-quality clinical trial monitoring and management for the purpose of providing clients with the most efficient services. In recent years, clinical trials have tended to be conducted in multiple countries. In response, EffPha has set its sights on the global market. EffPha has taken the initiative to build a global presence, expand CRO services for international multi-center clinical trials, and move forward with our long-term collaborative pharmaceutical partners.
Visit us to learn how EffPha can help support your drug development projects at https://www.effpha.com/.
更多參展商新聞稿
- 潤霈生技亞洲生技大展首度登場 眾多明星商品強力吸睛引爆熱潮 潤霈生技股份有限公司 / 2025-08-11
- 國鼎生技推進全球三期臨床在轉移胰臟癌一線治療 國鼎生物科技股份有限公司 / 2025-08-10
- 環球生技月刊報導:國鼎生技-開發Antroquinonol 造福抗癌研究治療 國鼎生物科技股份有限公司 / 2025-08-10
- 現場校正、抽檢應用 攜帶式測量儀 幸託有限公司 / 2025-08-07
- 鴻曜醫學取得生技醫藥產業發展條例資格審定 深耕台灣、邁向國際臨床規範 鴻曜醫學股份有限公司 / 2025-07-30
- 突破性幹細胞療法!鴻曜醫學MiSaver ⼼肌梗塞後修復效果顯著 鴻曜醫學股份有限公司 / 2025-07-30
- 鴻曜醫學邁向國際:幹細胞療法 MiSaver® 啟動跨國臨床試驗,打造心血管再生醫療新藍圖 鴻曜醫學股份有限公司 / 2025-07-28
- 思必瑞特生技首次亮相BioAsia!關鍵凍晶技術實現PRP精準醫療 思必瑞特生技股份有限公司 / 2025-07-28
- 賽博生醫攜手捷昇生物科技 引進RASTRUM™加速3D細胞列印與癌症藥物開發 賽博生醫股份有限公司 / 2025-07-27
- 賽博生醫推出FormuGel™ 3D細胞培養膠體平台,整合腫瘤建模×藥效分析×科研服務 賽博生醫股份有限公司 / 2025-07-26
- 賽博生醫攜手成大比較醫學研究中心 打造高通量高擬真的3D腫瘤藥篩平台 賽博生醫股份有限公司 / 2025-07-26
- 啟弘生技與AAVnerGene攜手合作下世代腺相關病毒(AAV)載體製程研發 啟弘生物科技股份有限公司 / 2025-07-25
- 7/24-7/27 GBC普生在 亞洲生技大展 與您相見 普生股份有限公司 / 2025-07-25
- 普生GBC CellBio™ a2000 榮獲2025愛迪生獎肯定 普生股份有限公司 / 2025-07-24
- 普生竹創大樓開幕啟用 AI精準醫療、大健康佈局再升級 普生股份有限公司 / 2025-07-24
- 誠邀蒞臨|4樓M412 展位「多家廠商聯合座談會」,精彩不容錯過! 利政科技股份有限公司 / 2025-07-24
- 中宇環保工程股份有限公司:生技製藥建廠與製程設備整合專家 利政科技股份有限公司 / 2025-07-24
- 專業實驗室儀器製造商- major science 利政科技 利政科技股份有限公司 / 2025-07-24
- 生展生技應邀參加 Bio Asia 2025 三大創新產品搶攻亞洲保健市場新藍海 ! 生展生物科技股份有限公司 / 2025-07-24
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 幸託有限公司 / 2025-07-24